Dow Jones

40,563.91

0.88%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

FUL Beewize spa

0.00

0.00 (0.00%)

Last Updated: -

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Beewize spa	BIT:FUL	Italy	Ordinary Share

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%							0.00	-

Director Declaration

16/05/2003 8:00am

UK Regulatory

RNS Number:1721L
Fulcrum Pharma PLC
16 May 2003



                               Fulcrum Pharma Plc

                      ("Fulcrum Pharma" or "the Company")

                                 Re Directorate

Further to the announcement on 7 May 2003 of the appointment of Dr Michael
Greenwood Carter, 63, as a non-executive director of the Company, the Company
announces the following details pursuant to Schedule 2 paragraph (f) of the AIM
Rules.

Dr Carter is or has been in the last five years a director of the following
companies:

Current                             Past

Galen Holdings plc                  Matrix Therapeutics Ltd

Metris Therapeutics Ltd             Cobra Therapeutics Ltd

Kudos Pharmaceuticals Ltd           Phairson Ltd

Genosis Inc                         Phairson Medical Ltd

Provensis Ltd                       Rodaris Pharmaceuticals Ltd

Micromet GmbH

Cancervax Inc

MGC Associates Ltd

Dr Carter was a non-executive director of Matrix Therapeutics Ltd when it went
into administrative receivership in December 2002.

END




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDNGUUCUAUPWGMA